Views & Analysis UK funding of cancer drugs: right, wrong, or just plain conf... How do the countries of the UK fund cancer drugs today, and do they have the right approaches?
Views & Analysis Immunotherapies in oncology: the future of cancer treatment ... Partnerships, co-marketing and the positioning of drugs are shaping the competitive landscape in oncology.
Views & Analysis Health literacy: help pharma communicate with patients Health literacy study suggests more than 90% of adults need health information to be written for a reading age of 9-11 years.
Views & Analysis Deep Dive: Oncology magazine launched today Are cancer screening and diagnosis swift enough, and how effective are the latest tailored drugs?
Views & Analysis To PSP or not to PSP? That is NOT the question A practical guide to planning and running an effective patient support programme.
Views & Analysis Non-profit model for childhood cancer drugs Charities must work to help pharma and academia prioritise and accelerate paediatric treatments.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
